Focal Therapy in Grade Group 3 Prostate Cancer.

Purpose Of This Review: Treatment of intermediate risk prostate cancer remains controversial. Clearly some patients with low volume favorable intermediate risk can be followed with active surveillance. Those with high volume bilateral disease need more radical whole gland therapy.